Freyr announces a strategic partnership with an Italy-based multinational pharmaceuticals company. The collaboration involves Regulatory support for NDA/MAA submissions.Rooting to Freyr’s outbound reach, the Italy-based pharma company joined multiple discussions with Freyr on varied requirements and took note of the Regulatory provider’s strong knowledge base, team structures, and cost-effective solutions. Eventually, the discussions awarded Freyr a project regarding NDA/MAA submissions.“At the outset, given the customer’s willingness to outsource Regulatory requirements itself is a big achievement for Freyr. Because they had historically proven to be unwilling to outsource their requirements. Their decision demonstrated how trustworthy our services are,” said Suren, CEO at Freyr. “With multiple projects signed and varied requirements already in the pipeline, Freyr is looking forward to having a long-term working relationship with the customer,” added Suren.